CFTR and cystic fibrosis: These results in non-CF HNE demonstrate that VX-445 stimulated It in a CFTR-dependent manner but did not affect total CFTR-mediated It, indicating that VX-445 may also be acting to potentiate CFTR in addition to its previously established mechanism of action as a CFTR corrector.